Future research should aim at identifying the FH patients at particularly high risk of premature cardiovascular disease. Individual regimens can then be developed to prevent premature death in patients with FH, who show different combinations of risk factors. However, all FH patients need to be treated. Because currently we are not able to identify whether or not a patient has high risk for cardiovascular disease before onset of symptoms.

Go to Comment Form